EUVIMEDEUVIMED entdecken
Crossref

Elevated Lactate-to-Albumin Ratio: A Critical Predictor of Adverse Outcomes in Coronary Syndrome

Perihan Varım, Ahmet Can Çakmak, Taner Demirci, Huriye Erdogan Dagdas, Ersan Tatlı

Konuralp Tip Dergisi · 24.03.2026 · 18 (1) · 30-34

DOI: 10.18521/ktd.1780067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Konuralp Tip Dergisi, online erschienen am 24.03.2026. Verfasst von Perihan Varım und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Gefördert von: This research received no external funding..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Acute coronary syndrome (ACS) encompasses a range of life-threatening conditions, including ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI), in which early mortality continues to pose a significant challenge. Prompt recognition of high-risk patients is crucial to enable timely interventions that may enhance survival outcomes. Current prognostic tools may not be sufficient for early risk assessment. The lactate-albumin ratio (LAR) is a promising, cost-effective marker that could help predict early mortality in ACS patients, enabling better risk stratification and improving clinical outcomeMaterial and Methods: This retrospective, single-center study included 200 hospitalized patients, comprising 100 with STEMI and 100 with NSTEMI. Laboratory analyses were performed on blood samples and arterial blood gas measurements obtained at the time of admission. In-hospital mortality and arrhythmia rates were compared between the groups based on the lactate-albumin ratio.

Results

LAR levels were compared based on mortality status. The median (IQR) LAR for deceased patients was 1.13 (0.53–1.30), significantly higher than that of surviving patients [median (IQR) LAR: 0.41 (0.32–0.54), p < 0.001]. At a cut-off value of 0.89, LAR had 73.3% sensitivity and 97.3% specificity for predicting mortality. Logistic regression analysis confirmed LAR as a strong predictor of mortality (Nagelkerke R² = 45.5%, B = 5.78, OR = 323, 95% CI: 35.45–2956, p < 0.001).

Conclusion

In acute coronary syndrome, the lactate–albumin ratio may serve as a practical biomarker for early risk stratification and identification of high-risk patients rather than as a diagnostic tool.

Förderung

  • This research received no external funding.

Zitieren

APA

Varım, P., Çakmak, A. C., Demirci, T., Dagdas, H. E., & Tatlı, E. (2026). Elevated Lactate-to-Albumin Ratio: A Critical Predictor of Adverse Outcomes in Coronary Syndrome. Konuralp Tip Dergisi, 18(1), 30-34. https://doi.org/10.18521/ktd.1780067

Vancouver

Varım P, Çakmak AC, Demirci T, Dagdas HE, Tatlı E. Elevated Lactate-to-Albumin Ratio: A Critical Predictor of Adverse Outcomes in Coronary Syndrome. Konuralp Tip Dergisi. 2026;18(1):30-34. doi:10.18521/ktd.1780067

BibTeX
@article{Varm2026,
  author = {Varım, Perihan and Çakmak, Ahmet Can and Demirci, Taner and Dagdas, Huriye Erdogan and Tatlı, Ersan},
  title = {Elevated Lactate-to-Albumin Ratio: A Critical Predictor of Adverse Outcomes in Coronary Syndrome},
  journal = {Konuralp Tip Dergisi},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {30--34},
  doi = {10.18521/ktd.1780067}
}
Kostenlos starten →